文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HPV16 和 HPV18 基因组结构、表达和转录后调控。

HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.

机构信息

Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.

出版信息

Int J Mol Sci. 2022 Apr 29;23(9):4943. doi: 10.3390/ijms23094943.


DOI:10.3390/ijms23094943
PMID:35563334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9105396/
Abstract

Human papillomaviruses (HPV) are a group of small non-enveloped DNA viruses whose infection causes benign tumors or cancers. HPV16 and HPV18, the two most common high-risk HPVs, are responsible for ~70% of all HPV-related cervical cancers and head and neck cancers. The expression of the HPV genome is highly dependent on cell differentiation and is strictly regulated at the transcriptional and post-transcriptional levels. Both HPV early and late transcripts differentially expressed in the infected cells are intron-containing bicistronic or polycistronic RNAs bearing more than one open reading frame (ORF), because of usage of alternative viral promoters and two alternative viral RNA polyadenylation signals. Papillomaviruses proficiently engage alternative RNA splicing to express individual ORFs from the bicistronic or polycistronic RNA transcripts. In this review, we discuss the genome structures and the updated transcription maps of HPV16 and HPV18, and the latest research advances in understanding RNA cis-elements, intron branch point sequences, and RNA-binding proteins in the regulation of viral RNA processing. Moreover, we briefly discuss the epigenetic modifications, including DNA methylation and possible APOBEC-mediated genome editing in HPV infections and carcinogenesis.

摘要

人乳头瘤病毒(HPV)是一组小型无包膜 DNA 病毒,其感染可导致良性肿瘤或癌症。HPV16 和 HPV18 是两种最常见的高危 HPV,它们导致了约 70%的所有 HPV 相关宫颈癌和头颈部癌症。HPV 基因组的表达高度依赖于细胞分化,并在转录和转录后水平受到严格调控。感染细胞中差异表达的 HPV 早期和晚期转录本是含有不止一个开放阅读框(ORF)的内含子双顺反子或多顺反子 RNA,这是因为使用了替代的病毒启动子和两个替代的病毒 RNA 多聚腺苷酸化信号。乳头瘤病毒能够有效地进行选择性 RNA 剪接,从双顺反子或多顺反子 RNA 转录本中表达单个 ORF。在这篇综述中,我们讨论了 HPV16 和 HPV18 的基因组结构和最新的转录图谱,以及在理解病毒 RNA 加工调控中的 RNA 顺式元件、内含子分支点序列和 RNA 结合蛋白方面的最新研究进展。此外,我们还简要讨论了 HPV 感染和致癌过程中的表观遗传修饰,包括 DNA 甲基化和可能的 APOBEC 介导的基因组编辑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/a46988276b8c/ijms-23-04943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/1852a1876b11/ijms-23-04943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/ff4c8f12317e/ijms-23-04943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/876cb8196be0/ijms-23-04943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/ab66207d36f2/ijms-23-04943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/15d1d41d31ac/ijms-23-04943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/a46988276b8c/ijms-23-04943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/1852a1876b11/ijms-23-04943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/ff4c8f12317e/ijms-23-04943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/876cb8196be0/ijms-23-04943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/ab66207d36f2/ijms-23-04943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/15d1d41d31ac/ijms-23-04943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360a/9105396/a46988276b8c/ijms-23-04943-g006.jpg

相似文献

[1]
HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.

Int J Mol Sci. 2022-4-29

[2]
Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.

J Virol. 2016-9-29

[3]
Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).

J Virol. 2015-5

[4]
HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.

mBio. 2024-5-8

[5]
The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.

J Virol. 2006-5

[6]
HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.

Papillomavirus Res. 2018-6

[7]
Papillomavirus genome structure, expression, and post-transcriptional regulation.

Front Biosci. 2006-9-1

[8]
Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.

Genomics. 2018-12-13

[9]
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.

mBio. 2021-1-19

[10]
Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.

J Virol. 2019-4-3

引用本文的文献

[1]
Detection of human papillomavirus in male genital samples.

World J Urol. 2025-8-20

[2]
Enhancing Wound Healing Through Secretome-Loaded 3D-Printed Biomaterials.

Gels. 2025-6-20

[3]
Human papillomavirus vaccine use in clinical practice - What dermatologists should know as health care providers.

Indian J Sex Transm Dis AIDS. 2025

[4]
Mechanisms of Viral DNA Replication of Human Papillomavirus: E2 Protein-Dependent Recruitment of E1 DNA Helicase to the Origin of DNA Replication.

Int J Mol Sci. 2025-5-2

[5]
Higher Expression of HPV16 Derived E7_LI Transcript Observed in Men With HIV and Recurrent Anal Cancer.

J Med Virol. 2025-5

[6]
Human papilloma virus (HPV) mediated cancers: an insightful update.

J Transl Med. 2025-4-29

[7]
Human papillomavirus E2 proteins suppress innate antiviral signaling pathways.

Front Immunol. 2025-4-8

[8]
The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle.

PLoS Pathog. 2025-4-9

[9]
Viral Appropriation of Specificity Protein 1 (Sp1): The Role of Sp1 in Human Retro- and DNA Viruses in Promoter Activation and Beyond.

Viruses. 2025-2-20

[10]
Improving HPV-related health literacy in the Austrian population - A participatory research approach.

Hum Vaccin Immunother. 2025-12

本文引用的文献

[1]
Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity.

mBio. 2022-2-22

[2]
Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.

J Virol. 2022-2-23

[3]
The chromatin insulator CTCF regulates HPV18 transcript splicing and differentiation-dependent late gene expression.

PLoS Pathog. 2021-11

[4]
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study.

Int J Cancer. 2022-1-15

[5]
Human papillomaviruses: diversity, infection and host interactions.

Nat Rev Microbiol. 2022-2

[6]
Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Mol Cell Biochem. 2021-12

[7]
APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.

Viruses. 2021-8-23

[8]
HPV transcript expression affects cervical cancer response to chemoradiation.

JCI Insight. 2021-8-23

[9]
Comprehensive RNP profiling in cells identifies U1 snRNP complexes with cleavage and polyadenylation factors active in telescripting.

Methods Enzymol. 2021

[10]
DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.

Gynecol Oncol. 2021-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索